肝细胞癌合并胆管癌栓的诊疗进展  

Advances in the diagnosis and treatment of hepatocellular carcinoma with bile duct tumor thrombus

作　　者：郭玉祥 王茂森 刘中原 张旭东[1] 马鹏飞 王向坤 李仁锋[1] GUO Yuxiang;WANG Maosen;LIU Zhongyuan;ZHANG Xudong;MA Pengfei;WANG Xiangkun;LI Renfeng(Department of Hepatic-biliary-pancreatic Surgery,The First Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,China)

机构地区：[1]郑州大学第一附属医院肝胆胰外科医学部,郑州450000

出　　处：《临床肝胆病杂志》2025年第2期359-364,共6页Journal of Clinical Hepatology

基　　金：国家自然科学基金(82270538,81800546);河南省自然科学基金(232300420038,232300420249)。

摘　　要：肝细胞癌合并胆管癌栓目前在临床上并不多见,且容易误诊,以往认为其是疾病进展至晚期的表现,且预后不佳,治疗常具有挑战性。然而,随着研究的不断深入,近年来对该疾病的认识不断深化,诊断和治疗理念也发生了显著变化,目前主要采取以手术为主的综合治疗,但在临床治疗策略选择方面仍存在争议。本文就该病的手术治疗方式以及预后进行详细探讨,以期为临床治疗选择提供参考。Hepatocellular carcinoma(HCC)with biliary duct tumor thrombus(BDTT)is currently not common in clinical practice and is easily misdiagnosed,and previously,it was often considered an advanced stage of the disease with a poor prognosis,making its treatment challenging.However,in-depth studies in recent years have gradually deepened our understanding of this disease,leading to significant changes in diagnostic and treatment concepts.Currently,comprehensive treatment,mainly surgery,is used for treatment,but there is still controversy over the selection of clinical treatment strategies.This article provides a detailed discussion on surgical methods and prognosis,in order to provide a reference for clinical treatment options.

关 键 词：癌 肝细胞 胆管癌栓 诊断 治疗学 预后 

分 类 号：R735.7[医药卫生—肿瘤] R735.8[医药卫生—临床医学]